RXO
Overvalued by 66.7% based on the discounted cash flow analysis.
Market cap | $4.29 Billion |
---|---|
Enterprise Value | $4.96 Billion |
Dividend Yield | $0 (0%) |
Earnings per Share | $0.03 |
Beta | 1.12 |
Outstanding Shares | 117,579,000 |
Return on Equity | - |
---|---|
Return on Assets | - |
Return on Invested Capital | - |
P/E Ratio | -152.35 |
---|---|
PEG | -142.83 |
Price to Sales | 0.47 |
Price to Book Ratio | 1.22 |
Enterprise Value to Revenue | 1.23 |
Enterprise Value to EBIT | -107.35 |
Enterprise Value to Net Income | -79 |
Total Debt to Enterprise | 0.14 |
Debt to Equity | 0.43 |
No data
No data